Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6596726B1 · kind B1 · utility
61Cited by
14References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 1997 |
| Grant date | Jul 22, 2003 |
| Priority date | — |
| Expiry date | Mar 6, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described are compounds of the following formula and a method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof, a compound of the formula: wherein the formula terms are described in the specification and wherein the members in the aforementioned structure are defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.